Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-10T22:12:58.776Z Has data issue: false hasContentIssue false
  • English
  • Français

The introduction of lung stereotactic body radiotherapy in the UK… it’s now a reality!

Published online by Cambridge University Press:  20 July 2011

A Needham ,
D Hutton  and
A Baker
A Needham*
Affiliation:
Radiotherapy Department, St James Institute of Oncology, Leeds, UK
D Hutton
Affiliation:
Radiotherapy Department, Clatterbridge Centre for Oncology, Wirral, UK
A Baker
Affiliation:
Radiotherapy Department, Clatterbridge Centre for Oncology, Wirral, UK
*
Correspondence to: A Needham, Radiotherapy Department, St James Institute of Oncology, Leeds, LS9 7JT, UK. E-mail: alan.needham@leedsth.nhs.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Lung stereotactic body radiotherapy (SBRT) is a novel and effective technique for the treatment of early stage non small cell lung cancer which is rapidly becoming the radiotherapy regime of choice for those patients unable or unwilling to undergo surgical resection.

Although introduced almost 20 years ago, it was not until the wider establishment of image guided radiotherapy (IGRT) techniques that many UK departments first considered and then succeeded in implementing lung SBRT. Many have been assisted in this through membership of the national UK SBRT consortium which aims to facilitate local introduction and to provide guidelines and practical support for the wider radiotherapy community.

This article will seek to place the introduction of SBRT within a broad historical context, outline basic principles for safe and effective practice and describe how such principles are currently being pursued in an era of IGRT. Additionally, the role of the UK SBRT consortium in implementation will be reported alongside the results of its first national survey on the subject.

Keywords

Lung cancerstereotactic body radiotherapyIGRTimage guided radiotherapyhypofractionation
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 11 , Issue 1 , March 2012 , pp. 7 - 15
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Lagerwaard, FJ, Haasbeek, CJ, Smit, EF, Slotman, BJ, Senan, S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 70:685–692.CrossRefGoogle ScholarPubMed
Timmerman, R, McGarry, R, Yiannoutsos, C, Papiez, L, Tudor, K, DeLuca, J, Ewing, M, Abdulrahman, R, DesRosiers, C, Williams, M, Fletcher, J. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24:4833–4839.CrossRefGoogle Scholar
Martel, MK, Ten Haken, RK, Hazuka, MB, Kessler, ML, Strawderman, M, Turrisi, AT, Lawrence, TS, Fraass, BA, Lichter, AS. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 1999; 24:31–37.CrossRefGoogle ScholarPubMed
Chi, A, Liao, Z, Nguyen, NP, Xu, J, Stea, B, Komaki, R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 2010; 94:1–11.CrossRefGoogle ScholarPubMed
Lax, I, Blomgren, H, Näslund, I, Svanström, R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33:677–683.CrossRefGoogle ScholarPubMed
Timmerman, R, Galvin, J, Michalski, J, Straube, W, Ibbott, G, Martin, E, Abdulrahman, R, Swann, S, Fowler, J, Choy, H. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer. Acta Oncol 2006; 45:779–786.CrossRefGoogle Scholar
Hurkmans, CW, Cuijpers, JP, Lagerwaard, FJ, Widder, J, van der Heide, UA, Schuring, D, Senan, S. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 2009; 4:1.CrossRefGoogle ScholarPubMed
UK SBRT Consortium. Stereotactic Body Radiation Therapy (SBRT) for patients with Early Stage Non-small Cell Lung cancer: A resource. (Oct 2010).Google Scholar
Damhuis, R, Coonar, A, Plaisier, P, Dankers, M, Bekkers, J, Linklater, K, Møller, H. A case-mix model for monitoring of postoperative mortality after surgery for lung cancer. Lung Cancer 2006; 51:123–129.CrossRefGoogle ScholarPubMed